Matsumori Akira
Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine.
Nihon Rinsho. 2003 May;61(5):745-50.
Cytokines are being increasingly recognized as important factors in the pathogenesis and pathophysiology of heart failure. Elevated levels of circulating cytokines have been reported in patients with heart failure, and various cytokines have been shown to depress myocardial contractility in vitro and in vivo. Our recent study showed that the various drugs for heart failure modulated the production of cytokines, and some of these drugs inhibited activation of NF-kappa B. Cytokine gene therapy which inhibits inflammatory response by viral IL-10 and IL-1 receptor antagonist has been shown to be effective in the animal models of heart failure. Mast cells have been shown to play important role in the pathogenesis of heart failure due to viral myocarditis, and transition from compensated hypertrophy to heart failure.
细胞因子日益被认为是心力衰竭发病机制和病理生理学中的重要因素。据报道,心力衰竭患者循环细胞因子水平升高,并且各种细胞因子已被证明在体外和体内均可降低心肌收缩力。我们最近的研究表明,各种心力衰竭药物可调节细胞因子的产生,其中一些药物可抑制核因子κB的激活。通过病毒白细胞介素-10和白细胞介素-1受体拮抗剂抑制炎症反应的细胞因子基因治疗已被证明在心力衰竭动物模型中有效。肥大细胞已被证明在病毒性心肌炎所致心力衰竭的发病机制以及从代偿性肥大向心力衰竭的转变中起重要作用。